H2020FP7HORIZON
Region Hovedstaden
- Country
- DKDenmark
- Defence projects
- 0
- Projects, all programmes
- 182
- As coordinator
- 25
- EU contribution (CORDIS)
- EUR 93,075,925
- Active
- 2008 to 2025
Projects
182 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| NYMPHA-MDNext Generation Mobile Platforms for HeAlth, in Mental Disorders. | FP7 | 2014 | Participant | EUR 171,307 |
| ENABLEEuropean Gram Negative Antibacterial Engine | FP7 | 2014 | Participant | EUR 1,011,953 |
| PredictNDFrom Patient Data to Clinical Diagnosis in Neurodegenerative Diseases | FP7 | 2014 | Participant | EUR 365,570 |
| DISCHARGEDiagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies | FP7 | 2014 | Participant | EUR 222,126 |
| POANPathogenesis of autoimmune neurodegeneration: What causes the immune system to destroy healthy neurons? | H2020 | 2014 | Coordinator | EUR 100,000 |
| EUROHEADPAINMechanisms and Treatment of Migraine and its Chronification | FP7 | 2014 | Participant | EUR 711,320 |
| INFECTImproving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures that Dictate Severity of Tissue Infection | FP7 | 2013 | Participant | EUR 1,607,774 |
| TransCardTranslating disease to cardiovascular health | FP7 | 2013 | Participant | EUR 771,500 |
| IFAAMIntegrated Approaches to Food Allergen and Allergy Risk Management | FP7 | 2013 | Participant | EUR 496,046 |
| CHEMOGUIDEChemotherapy guidance based on efficacy of treatment regimen in cancer cells from the individual patient | FP7 | 2013 | Participant | EUR 141,800 |
| TACTICTargeted Action for Curing Trauma Induced Coagulopathy | FP7 | 2013 | Coordinator | EUR 3,482,610 |
| CENTER-TBICollaborative European NeuroTrauma Effectiveness Research in TBI | FP7 | 2013 | Participant | EUR 46,924 |
| NEUVASCHEMIANeurovascular coupling in stroke - the brain microvasculature as a target for prevention of ischemic brain damage | FP7 | 2013 | Coordinator | EUR 204,931 |
| EU-CERT-ICDComparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope | FP7 | 2013 | Participant | EUR 249,133 |
| ECRANEuropean Communication on Research Awareness Needs | FP7 | 2012 | Participant | EUR 173,420 |
| PRIORITYProteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria | FP7 | 2012 | Coordinator | EUR 438,931 |
| ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk | FP7 | 2012 | Participant | EUR 306,812 |
| PSYCHDPCPsychiatric Diagnostic and Prevention Consortium | FP7 | 2012 | Participant | EUR 292,129 |
| EUROHYP-1European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke | FP7 | 2012 | Participant | EUR 533,808 |
| IMMOMECIMmune MOdulating strategies for treatment of MErkel cell Carcinoma | FP7 | 2012 | Participant | EUR 503,948 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.